BBC Virtus LifeSci Biotech Clinical Trials ETF

46

NYSE ARCA | ETF

Price
$19.74
Decreased by -0.35%
Dollar volume (20D)
859.53 K
ADR%
3.14
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.

The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Top 20 Holdings

Asset Name Sector Industry Weight
ALPN Alpine Immune Sciences Inc Healthcare Biotechnology 2.68%
LBPH Longboard Pharmaceuticals Inc Healthcare Biotechnology 2.54%
NVAX Novavax Inc Healthcare Biotechnology 2.12%
GERN Geron Corporation Healthcare Biotechnology 1.84%
6XC SOLENO THERAPEUT. DL-001 Healthcare Biotechnology 1.76%
MORF Morphic Holding Inc Healthcare Biotechnology 1.74%
VERV Verve Therapeutics Inc Healthcare Biotechnology 1.54%
KRYS Krystal Biotech Inc Healthcare Biotechnology 1.28%
NK NantKwest Inc Healthcare Biotechnology 1.23%
RGNX Regenxbio Inc Healthcare Biotechnology 1.10%
KRTX Karuna Therapeutics Inc Healthcare Biotechnology 1.10%
CBAY Cymabay Therapeu Healthcare Biotechnology 1.09%
PHAT Phathom Pharmaceuticals Inc Healthcare Biotechnology 1.06%
PRTA Prothena Corporation plc Healthcare Biotechnology 1.05%
INBX Inhibrx Inc Healthcare Biotechnology 1.04%
ZYME Zymeworks Inc. Common Stock Healthcare Biotechnology 0.98%
NUVB Nuvation Bio Inc Healthcare Biotechnology 0.98%
MDGL Madrigal Pharmaceuticals Inc Healthcare Biotechnology 0.98%
NTLA Intellia Therapeutics Inc Healthcare Biotechnology 0.97%
CNTA Centessa Pharmaceuticals PLC ADR Healthcare Biotechnology 0.95%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY